Nirmeen A. Kishk

1.2k total citations
65 papers, 641 citations indexed

About

Nirmeen A. Kishk is a scholar working on Psychiatry and Mental health, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Nirmeen A. Kishk has authored 65 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Psychiatry and Mental health, 23 papers in Neurology and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Nirmeen A. Kishk's work include Epilepsy research and treatment (26 papers), Multiple Sclerosis Research Studies (17 papers) and Pharmacological Effects and Toxicity Studies (14 papers). Nirmeen A. Kishk is often cited by papers focused on Epilepsy research and treatment (26 papers), Multiple Sclerosis Research Studies (17 papers) and Pharmacological Effects and Toxicity Studies (14 papers). Nirmeen A. Kishk collaborates with scholars based in Egypt, United States and Austria. Nirmeen A. Kishk's co-authors include Hala Gabr, Sherif Hamdy, Hayam Mahmoud, Lamia Afifi, Nevin Shalaby, Amr Hassan, Hatem Shehata, Alaa Elmazny, Amal Adnan Ashour and Gamal A. Mohamed and has published in prestigious journals such as SHILAP Revista de lepidopterología, Epilepsia and The Journal of Nervous and Mental Disease.

In The Last Decade

Nirmeen A. Kishk

57 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nirmeen A. Kishk Egypt 14 212 167 159 113 94 65 641
Peter Herkenrath Germany 16 64 0.3× 146 0.9× 90 0.6× 32 0.3× 81 0.9× 37 717
Anna V. Leonard Australia 13 136 0.6× 37 0.2× 258 1.6× 29 0.3× 136 1.4× 29 747
Serap Teber Türkiye 14 59 0.3× 137 0.8× 89 0.6× 21 0.2× 31 0.3× 75 468
James P. Caruso United States 14 66 0.3× 50 0.3× 234 1.5× 37 0.3× 139 1.5× 59 526
Neşe Tuncer Türkiye 12 38 0.2× 62 0.4× 200 1.3× 35 0.3× 75 0.8× 25 572
Carl‐Albrecht Haensch Germany 12 92 0.4× 122 0.7× 235 1.5× 12 0.1× 52 0.6× 39 617
A. Gordon Smith United States 12 43 0.2× 81 0.5× 242 1.5× 24 0.2× 70 0.7× 27 506
Oliver Maier Germany 13 98 0.5× 146 0.9× 110 0.7× 24 0.2× 51 0.5× 61 862
Figen Gökçay Türkiye 16 172 0.8× 330 2.0× 330 2.1× 15 0.1× 41 0.4× 60 855
A Buge France 15 205 1.0× 87 0.5× 482 3.0× 48 0.4× 148 1.6× 94 1.1k

Countries citing papers authored by Nirmeen A. Kishk

Since Specialization
Citations

This map shows the geographic impact of Nirmeen A. Kishk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirmeen A. Kishk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirmeen A. Kishk more than expected).

Fields of papers citing papers by Nirmeen A. Kishk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirmeen A. Kishk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirmeen A. Kishk. The network helps show where Nirmeen A. Kishk may publish in the future.

Co-authorship network of co-authors of Nirmeen A. Kishk

This figure shows the co-authorship network connecting the top 25 collaborators of Nirmeen A. Kishk. A scholar is included among the top collaborators of Nirmeen A. Kishk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirmeen A. Kishk. Nirmeen A. Kishk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kishk, Nirmeen A., et al.. (2025). The Impact of Transcranial Direct Current Stimulation on Drug-Resistant Temporal Lobe Epilepsy. Journal of Clinical Neurophysiology. 43(3). 253–258.
2.
Kishk, Nirmeen A., Reham Shamloul, Rehab Magdy, et al.. (2024). Epilepsy Arabic renaming to cerebroelectric disorder could minimize the stigma. Epilepsy Research. 210. 107495–107495.
3.
4.
Kishk, Nirmeen A., et al.. (2024). Impact of COVID-19 vaccination in patients with epilepsy. The Egyptian Journal of Neurology Psychiatry and Neurosurgery. 60(1).
6.
Kishk, Nirmeen A., et al.. (2023). Cost-effectiveness of HARNESS-MRI protocol in focal drug-resistant epilepsy in a limited-resources country: An Egyptian study. Clinical Neurology and Neurosurgery. 233. 107946–107946. 2 indexed citations
7.
Kishk, Nirmeen A., et al.. (2023). Patterns and predictors of sexual dysfunction in women with epilepsy. Epilepsy & Behavior. 147. 109421–109421. 1 indexed citations
8.
Kishk, Nirmeen A., et al.. (2023). Validation of brain parenchyma sonography as a marker of neurodegeneration in multiple sclerosis. The Egyptian Journal of Neurology Psychiatry and Neurosurgery. 59(1). 1 indexed citations
9.
Pichon, Jean‐Baptiste Le, et al.. (2022). The use of virtual tools in narrowing the impact of health disparities in neurology. Frontiers in Pediatrics. 10. 1028833–1028833. 3 indexed citations
10.
Wiebe, Samuel, Ali A. Asadi‐Pooya, Ganna Balagura, et al.. (2021). The initial impact of the SARS‐CoV‐2 pandemic on epilepsy research. Epilepsia Open. 6(2). 255–265. 1 indexed citations
11.
Kishk, Nirmeen A., et al.. (2021). Characteristics and outcome in an Egyptian Cohort with status epilepticus. Acta Neurologica Scandinavica. 144(4). 375–382.
12.
Magdy, Rehab, et al.. (2021). Risk estimation of SUDEP during COVID-19 pandemic era in a tertiary referral center. Epilepsy Research. 173. 106625–106625. 3 indexed citations
13.
Cross, J. Helen, Churl‐Su Kwon, Ali A. Asadi‐Pooya, et al.. (2021). Epilepsy care during the COVID‐19 pandemic. Epilepsia. 62(10). 2322–2332. 50 indexed citations
14.
Magdy, Rehab, et al.. (2020). Predictors of successful Ramadan fasting in Muslim patients with epilepsy: A prospective study. Seizure. 80. 67–70. 7 indexed citations
15.
Hamdy, Sherif, Maged Abdel Naseer, Hatem Shehata, et al.. (2020). <p>Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach</p>. Therapeutics and Clinical Risk Management. Volume 16. 651–662. 11 indexed citations
16.
Hamdy, Sherif, Maged Abdel Naseer, Hatem Shehata, et al.. (2020). <p>Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era</p>. Therapeutics and Clinical Risk Management. Volume 16. 759–767. 3 indexed citations
17.
Kissani, Najib, Boulenouar Mesraoua, Fatema Abdulla, et al.. (2020). Epilepsy and school in the Middle East and North Africa (MENA) region: The current situation, challenges, and solutions. Epilepsy & Behavior. 112. 107325–107325. 3 indexed citations
18.
Kishk, Nirmeen A., et al.. (2019). <p>Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis</p>. Neuropsychiatric Disease and Treatment. Volume 15. 2571–2578. 10 indexed citations
19.
Kishk, Nirmeen A., Yehia Z. Gad, Mohamed A. M. Ali, et al.. (2017). Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases. Journal of the Neurological Sciences. 383. 188–198. 41 indexed citations
20.
Kishk, Nirmeen A., et al.. (2015). Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients. Journal of Clinical Neuroscience. 22(4). 670–675. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026